Congenital localized scleroderma

Francesco Zulian, Cristina Vallongo, Sheila Knupp Feitosa de Oliveira, Marilynn G. Punaro, Joan Ros, Henryka Mazur-Zielinska, Paul Galea, Liviana Da Dalt, Lawrence F. Eichenfield

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Objectives: Juvenile localized scleroderma (JLS) usually has its onset during later childhood. This report describes the clinical and serologic features of six children with congenital localized scleroderma (CLS). Study design: A large, multinational study was conducted among pediatric rheumatology and dermatology centers by collecting information on demographics, family history, triggering environmental factors, clinical features, laboratory reports, and treatment of patients with JLS. Patients with onset at birth were carefully examined. Results: Among 750 patients with JLS, 6 patients (0.8%) had scleroderma-related lesions at birth. Female-to-male ratio was 2:1. All patients had linear scleroderma, in four involving the face with en coup de sabre appearance. Two patients were misdiagnosed as having skin infection, one nevus, one salmon patch, and two undefined skin lesions. The mean diagnostic delay was 3.9 years. In comparison with the group of 733 patients with late-onset JLS, CLS presented a significantly more prolonged disease duration at diagnosis and a higher frequency of en coup de sabre subtypes. Conclusions: Congenital localized scleroderma is a rare and probably underestimated condition in neonates. The linear subtype was the exclusive manifestation of the disease. CLS should be included in the differential diagnosis of infants with cutaneous erythematous fibrotic lesions to avoid functional and aesthetic sequelae and to allow prompt therapy.

Original languageEnglish (US)
Pages (from-to)248-251
Number of pages4
JournalJournal of Pediatrics
Volume149
Issue number2
DOIs
StatePublished - Aug 2006

Fingerprint

Localized Scleroderma
Skin
Parturition
Information Centers
Salmon
Nevus
Rheumatology
Dermatology
Diagnostic Errors
Esthetics
Differential Diagnosis
Demography
Newborn Infant
Pediatrics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Zulian, F., Vallongo, C., de Oliveira, S. K. F., Punaro, M. G., Ros, J., Mazur-Zielinska, H., ... Eichenfield, L. F. (2006). Congenital localized scleroderma. Journal of Pediatrics, 149(2), 248-251. https://doi.org/10.1016/j.jpeds.2006.04.052

Congenital localized scleroderma. / Zulian, Francesco; Vallongo, Cristina; de Oliveira, Sheila Knupp Feitosa; Punaro, Marilynn G.; Ros, Joan; Mazur-Zielinska, Henryka; Galea, Paul; Da Dalt, Liviana; Eichenfield, Lawrence F.

In: Journal of Pediatrics, Vol. 149, No. 2, 08.2006, p. 248-251.

Research output: Contribution to journalArticle

Zulian, F, Vallongo, C, de Oliveira, SKF, Punaro, MG, Ros, J, Mazur-Zielinska, H, Galea, P, Da Dalt, L & Eichenfield, LF 2006, 'Congenital localized scleroderma', Journal of Pediatrics, vol. 149, no. 2, pp. 248-251. https://doi.org/10.1016/j.jpeds.2006.04.052
Zulian F, Vallongo C, de Oliveira SKF, Punaro MG, Ros J, Mazur-Zielinska H et al. Congenital localized scleroderma. Journal of Pediatrics. 2006 Aug;149(2):248-251. https://doi.org/10.1016/j.jpeds.2006.04.052
Zulian, Francesco ; Vallongo, Cristina ; de Oliveira, Sheila Knupp Feitosa ; Punaro, Marilynn G. ; Ros, Joan ; Mazur-Zielinska, Henryka ; Galea, Paul ; Da Dalt, Liviana ; Eichenfield, Lawrence F. / Congenital localized scleroderma. In: Journal of Pediatrics. 2006 ; Vol. 149, No. 2. pp. 248-251.
@article{2d33564710ae45ff9f75d0e6d4500909,
title = "Congenital localized scleroderma",
abstract = "Objectives: Juvenile localized scleroderma (JLS) usually has its onset during later childhood. This report describes the clinical and serologic features of six children with congenital localized scleroderma (CLS). Study design: A large, multinational study was conducted among pediatric rheumatology and dermatology centers by collecting information on demographics, family history, triggering environmental factors, clinical features, laboratory reports, and treatment of patients with JLS. Patients with onset at birth were carefully examined. Results: Among 750 patients with JLS, 6 patients (0.8{\%}) had scleroderma-related lesions at birth. Female-to-male ratio was 2:1. All patients had linear scleroderma, in four involving the face with en coup de sabre appearance. Two patients were misdiagnosed as having skin infection, one nevus, one salmon patch, and two undefined skin lesions. The mean diagnostic delay was 3.9 years. In comparison with the group of 733 patients with late-onset JLS, CLS presented a significantly more prolonged disease duration at diagnosis and a higher frequency of en coup de sabre subtypes. Conclusions: Congenital localized scleroderma is a rare and probably underestimated condition in neonates. The linear subtype was the exclusive manifestation of the disease. CLS should be included in the differential diagnosis of infants with cutaneous erythematous fibrotic lesions to avoid functional and aesthetic sequelae and to allow prompt therapy.",
author = "Francesco Zulian and Cristina Vallongo and {de Oliveira}, {Sheila Knupp Feitosa} and Punaro, {Marilynn G.} and Joan Ros and Henryka Mazur-Zielinska and Paul Galea and {Da Dalt}, Liviana and Eichenfield, {Lawrence F.}",
year = "2006",
month = "8",
doi = "10.1016/j.jpeds.2006.04.052",
language = "English (US)",
volume = "149",
pages = "248--251",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Congenital localized scleroderma

AU - Zulian, Francesco

AU - Vallongo, Cristina

AU - de Oliveira, Sheila Knupp Feitosa

AU - Punaro, Marilynn G.

AU - Ros, Joan

AU - Mazur-Zielinska, Henryka

AU - Galea, Paul

AU - Da Dalt, Liviana

AU - Eichenfield, Lawrence F.

PY - 2006/8

Y1 - 2006/8

N2 - Objectives: Juvenile localized scleroderma (JLS) usually has its onset during later childhood. This report describes the clinical and serologic features of six children with congenital localized scleroderma (CLS). Study design: A large, multinational study was conducted among pediatric rheumatology and dermatology centers by collecting information on demographics, family history, triggering environmental factors, clinical features, laboratory reports, and treatment of patients with JLS. Patients with onset at birth were carefully examined. Results: Among 750 patients with JLS, 6 patients (0.8%) had scleroderma-related lesions at birth. Female-to-male ratio was 2:1. All patients had linear scleroderma, in four involving the face with en coup de sabre appearance. Two patients were misdiagnosed as having skin infection, one nevus, one salmon patch, and two undefined skin lesions. The mean diagnostic delay was 3.9 years. In comparison with the group of 733 patients with late-onset JLS, CLS presented a significantly more prolonged disease duration at diagnosis and a higher frequency of en coup de sabre subtypes. Conclusions: Congenital localized scleroderma is a rare and probably underestimated condition in neonates. The linear subtype was the exclusive manifestation of the disease. CLS should be included in the differential diagnosis of infants with cutaneous erythematous fibrotic lesions to avoid functional and aesthetic sequelae and to allow prompt therapy.

AB - Objectives: Juvenile localized scleroderma (JLS) usually has its onset during later childhood. This report describes the clinical and serologic features of six children with congenital localized scleroderma (CLS). Study design: A large, multinational study was conducted among pediatric rheumatology and dermatology centers by collecting information on demographics, family history, triggering environmental factors, clinical features, laboratory reports, and treatment of patients with JLS. Patients with onset at birth were carefully examined. Results: Among 750 patients with JLS, 6 patients (0.8%) had scleroderma-related lesions at birth. Female-to-male ratio was 2:1. All patients had linear scleroderma, in four involving the face with en coup de sabre appearance. Two patients were misdiagnosed as having skin infection, one nevus, one salmon patch, and two undefined skin lesions. The mean diagnostic delay was 3.9 years. In comparison with the group of 733 patients with late-onset JLS, CLS presented a significantly more prolonged disease duration at diagnosis and a higher frequency of en coup de sabre subtypes. Conclusions: Congenital localized scleroderma is a rare and probably underestimated condition in neonates. The linear subtype was the exclusive manifestation of the disease. CLS should be included in the differential diagnosis of infants with cutaneous erythematous fibrotic lesions to avoid functional and aesthetic sequelae and to allow prompt therapy.

UR - http://www.scopus.com/inward/record.url?scp=33746599046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746599046&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2006.04.052

DO - 10.1016/j.jpeds.2006.04.052

M3 - Article

C2 - 16887444

AN - SCOPUS:33746599046

VL - 149

SP - 248

EP - 251

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 2

ER -